Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

Uveal melanoma (UM) is the most common intraocular malignancy in adults and shows a high rate of metastatic spread. As randomized clinical trials with immune checkpoint inhibitors (ICI) have not been performed in patients with metastatic UM, we analyzed the real-world outcomes in a nationwide popula...

Full description

Bibliographic Details
Main Authors: Kalijn Fredrike Bol, Eva Ellebaek, Lise Hoejberg, Mette Marie Bagger, Mathilde Skaarup Larsen, Tobias Wirenfeldt Klausen, Ulrich Heide Køhler, Henrik Schmidt, Lars Bastholt, Jens Folke Kiilgaard, Marco Donia, Inge Marie Svane
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Cancers
Subjects:
uveal melanoma
immunotherapy
immune checkpoint inhibitors
real-world data
Online Access:https://www.mdpi.com/2072-6694/11/10/1489

Internet

https://www.mdpi.com/2072-6694/11/10/1489

Similar Items